Prosecution Insights
Last updated: April 19, 2026

Immusoft Corporation

2 pending office actions

Portfolio Summary

2
Total Pending OAs
2
Final Rejections
0
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17886337 B CELLS FOR IN VIVO DELIVERY OF THERAPEUTIC AGENTS WESTON, ALYSSA G 1633 Final Rejection Aug 11, 2022
16981618 B CELLS GENETICALLY ENGINEERED TO SECRETE FOLLISTATIN AND METHODS OF USING THE SAME TO TREAT FOLLISTATIN-RELATED DISEASES, CONDITIONS, DISORDERS AND TO ENHANCE MUSCLE GROWTH AND STRENGTH REGLAS, GEORGIANA C 1651 Final Rejection Sep 16, 2020

Managing Immusoft Corporation's Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month